Selection of monoclonal antibodies detecting KM01 antigen

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• KM01 antigen is detected in the serum of patients with colorectal and other gastrointestinal carcinomas.
• Development of sensitive and specific diagnostic systems for cancer detection is crucial.

Purpose of the Study:

• To select monoclonal antibodies (MoAbs) that specifically inhibit the binding of KM01 to the KM01 antigen.
• To evaluate the utility of these MoAbs for a next-generation KM01 antigen-detecting system.

Main Methods:

• Selection of MoAbs based on their ability to inhibit KM01 binding to the KM01 antigen.
• Testing of 91 MoAbs for inhibitory activity.
• Assessment of MoAb reactivity with a glycolipid antigen isolated from a cancer cell line.

Main Results:

• Eight out of 91 tested MoAbs exhibited specific binding inhibition of KM01.
• The reactivity profile of these selected MoAbs with the isolated glycolipid antigen closely matched that observed in cancer patient sera.
• These MoAbs demonstrated specific recognition of the KM01 antigen.

Conclusions:

• The selected MoAbs are effective inhibitors of KM01 binding to its antigen.
• These MoAbs hold potential for use in an improved KM01 antigen-detection system.
• The findings suggest a valuable application of these MoAbs in the diagnosis of gastrointestinal and colorectal carcinomas.